Background
3 The corporate plaintiffs, through a somewhat complex trust structure, comprise what may be conveniently described as the Tony Ferguson group of companies (the group). The group operates a business that sells a range of weight loss products including shakes, breakfast muesli and bars, and soups, and operates the Tony Ferguson Weight Loss Program (collectively, the business). The products sold by the business are manufactured by Jalco Food and Beverage Pty Limited (Jalco Food), a company associated with Mr Barry Smorgon and Mr John Tisdale, two of the directors of the corporate plaintiffs. The products are manufactured pursuant to contractual arrangements between Jalco Food and the fifth and sixth plaintiffs.
4 Under the present group structure, the seventh plaintiff functions as a holding company for the group. It owns all the shares in the second plaintiff which, in turn, owns all the units in four separate unit trusts of which the third, fifth, sixth, and eighth plaintiffs are, respectively, trustees. The second plaintiff collects money from the bank accounts of each of the unit trusts and pays the liabilities of those trusts as required.
5 The third plaintiff is the main operating entity within the group. It holds the rights to conduct the Tony Ferguson Weight Loss Program (the program) and licences Amnesiac Australia Holdings Pty Ltd (Amnesiac) and Jalco International Pty Ltd (Jalco International) to conduct the program internationally, other than in New Zealand. To that end, Amnesiac has granted a number of licences to third parties. The third plaintiff occupies premises at 4 Production Place, Penrith, New South Wales for the purpose of conducting its operations. It occupies those premises under informal arrangements whereby it is responsible for the payment of rent.
6 The eighth plaintiff was responsible for the operation of "stand-alone stores" which offered the program directly to consumers. It is also responsible for conducting online sales. At the time of Mr Farnsworth's appointment, there were no stand-alone stores. However, the eighth plaintiff continues to conduct online sales for the business. The eighth plaintiff occupies premises at Riverdale Shopping Centre, Dubbo, New South Wales for the purpose of conducting its operations. It occupies those premises under informal arrangements whereby it is responsible for the payment of rent.
7 The fifth plaintiff owns the intellectual property that forms part of the program. It also jointly owns with Jalco Food the formulae for certain products supplied under the manufacturing arrangements with that company. The fifth plaintiff licences the intellectual property to the third plaintiff for use in Australia and New Zealand. It also licences the intellectual property to Amnesiac and Jalco International for use by them in conducting the program internationally.
8 The fourth plaintiff is wholly owned by the seventh plaintiff. It owns and distributes a range of weight loss products which are separate from those involved in the program. Nevertheless, its operations are part of the business conducted by the group.
9 The day-to-day operations of the business are conducted using the distribution and warehousing services of Symbion Pty Limited (Symbion). It is not necessary for me to detail the arrangements by which, or manner in which, Symbion provides those services, other than to note the following matters. Requests for products are placed by retailers (mainly chemists, particularly Terry White Chemists) with Symbion who then places orders on the third plaintiff. The third plaintiff, in turn, places orders with Jalco Food. The third plaintiff raises invoices to Symbion for payment. However, these invoices are factored by the third plaintiff to Bibby Financial Services Australia Pty Limited (Bibby) who makes payment to the third plaintiff of approximately 80% of the face value of each invoice.
10 The role played by Symbion in the operation of the business is governed by a written contractual arrangement to which the third, fifth, and eighth plaintiffs are parties. Pursuant to that arrangement, Symbion is responsible for operating warehouse facilities for the products to be distributed. Prior to Mr Farnsworth's appointment, Symbion was required to vacate the premises from which its warehouse was operated. Mr Farnsworth's investigations have led him to understand that the original contractual arrangement to which Symbion was a party has been varied to remove the requirement that it operate a warehouse. There has been a dispute concerning the new arrangement. However, since his appointment, Mr Farnsworth has reached an agreement with Symbion whereby its involvement in the present operation of the business will continue until 2 October 2013, unless his administrations end earlier. Mr Farnsworth's evidence was that, if extensions of the convening periods were granted, he believed he would be able to agree with Symbion to continue its present distribution arrangements in respect of the business.
11 Bibby holds registered security interests over all the present and after-acquired property of the third, fifth, sixth, seventh, and eighth plaintiffs. The total amount of the debts purportedly secured is approximately $533,804.09. Bibby has been given notice of the present application. It has provided written acknowledgement that it does not oppose the extensions sought by Mr Farnsworth or the consequential relief he seeks relating to the time at which the second meetings of creditors are to be held.
12 Mr Farnsworth's evidence was that he has continued to receive payments from Bibby as invoices issued to Symbion are factored. Financial forecasts provided to him indicate that, at the least, the business will break even during the extended convening periods that have been sought.
13 On 23 August 2013, Mr Farnsworth caused advertisements to be published in the Australian Financial Review seeking expressions of interest in the purchase of the business. He has received four expressions of interest, all of which are non-binding and subject to a period of due diligence.
14 There are two matters to be noted in respect of any sale of the business. The first is that some of the products supplied by the business are regulated under the Therapeutic Goods Act 1989 (Cth) by the Therapeutic Goods Administration (the TGA). Mr Farnsworth has advised that, because of the nature of these products, any sale of the business may require approval by the TGA. The second is that part of the group's business arrangements involve third-line forcing which has been notified under the Competition and Consumer Act 2010 (Cth). Mr Farnsworth has advised that any sale of the business will involve consideration of these arrangements and likely further approval by the Australian Competition and Consumer Commission (the ACCC) having regard to the identity of the intending purchaser. His evidence was that this may take some time.
15 It is Mr Farnsworth's opinion, given the:
required periods of due diligence, which are ongoing;
negotiations with parties on terms of sale; and
likely complexities in preparing contracts for the sale of the business, including potential issues involving the TGA, the ACCC, and the various licensing arrangements that have been entered into,
that the sale process will not be complete for at least one month.
16 Mr Farnsworth's evidence was that, on the information available to him to date, a sale of the business is likely to take a substantial part of the period of the extensions he has sought. It would then be necessary to prepare a report to creditors with respect to any sale, its conditions, and any deed of company arrangement proposal to be put forward, which is highly likely to take into account, or be conditional on, the sum available to creditors after any sale of the business.
17 In this connection, Mr Farnsworth said that any deed of company arrangement proposal is likely to be a pooled one involving all of the corporate plaintiffs. Mr Farnsworth said that, until a sale of the business is completed, it would not be possible to estimate the recoveries that will be made from the assets of each corporate plaintiff. As such, it would be difficult to put forward any deed of company arrangement proposal. The likely position of each corporate plaintiff on a liquidation would not be clear until the business is sold and the assets of each corporate plaintiff are allocated a value. The proceeds of the sale are proposed to be included as part of any deed of company arrangement proposal.
18 Given that no proposal for a deed of company arrangement has yet been received, nor will one be received prior to the sale of the business, Mr Farnsworth said that it is likely that, were the second meeting of creditors of each corporate plaintiff to be held as presently required, each corporate plaintiff would be placed into liquidation at those meetings. Importantly, he said that, in his experience, a higher price for the sale of the business is likely to be received if the sale is effected during the administration of each corporate plaintiff as opposed to during a liquidation of them. Plainly, a higher sale price for the business is in the interests of all creditors.
19 Another matter to be noted is that a Report as to Affairs has not yet been prepared and completed by the directors of the corporate plaintiffs.